Research Article

Hybrid (2D/3D) Dosimetry of Radiolabeled Gold Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer

Table 1

Patients with breast cancer included in the SLN detection protocol with99mTc-AuNP-mannose.

Patient no.AgeDisease

147Ductal carcinoma in situ
229Ductal carcinoma in situ (T1a)
371Ductal carcinoma in situ (T1b)
476Ductal carcinoma in situ
545Ductal carcinoma in situ (T1a)

According to the TNM classification of malignant tumors [17].